Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1988 Jan;63(1):133–137.

Human T-cell activation: comparative studies on the role of different phorbol esters.

J F Dobbs 1, D R Katz 1
PMCID: PMC1454698  PMID: 3257457

Abstract

We confirm here previous studies that have shown synergy between anti-CD3 and phorbol esters in the induction of T-cell proliferation. However, for this study we have used tonsillar rather than peripheral blood T cells, and have compared the role of different phorbol esters rather than different anti-CD3 antibodies in the activation process. Three phorbol esters (phorbol myristate acetate, -dibenzoate and -didecanoate) showed a synergistic relationship. However, the concentration of the dibenzoate and the didecanoate forms required was higher than the concentration of myristate acetate. A second group of phorbol esters (alpha-phorbol didecanoate, a beta phorbol with no side chain, and a monomyristate) did not activate T cells. This difference in activation efficiency between the phorbol derivatives correlates with the pattern of neutrophil activation that has been described previously using the same compounds. In contrast to both the neutrophil and the proliferation studies, if the T cells were preincubated with the different phorbol esters and then subsequently cultured with anti-CD3, the pattern of response was different. Only phorbol myristate acetate induced a proliferative response; all the other compounds were inactive. Taken in conjunction with the known structural differences between the different phorbol derivatives, these results suggest that the relative lipophilic properties of the different molecules which activate T cells may be an important determinant in the induction of a response. Thus changes in the relative lipophilic properties of an antigen could be one way to alter its relative immunogenicity.

Full text

PDF
133

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blumberg P. M. In vitro studies on the mode of action of the phorbol esters, potent tumor promoters, part 2. Crit Rev Toxicol. 1981 Jun;8(3):199–234. doi: 10.3109/10408448109109658. [DOI] [PubMed] [Google Scholar]
  2. Blumberg P. M. In vitro studies on the mode of action of the phorbol esters, potent tumor promoters: part 1. Crit Rev Toxicol. 1980 Dec;8(2):153–197. doi: 10.3109/10408448009037493. [DOI] [PubMed] [Google Scholar]
  3. Brennan A., Katz D. R., Nunn J. D., Barker S., Hewison M., Fraher L. J., O'Riordan J. L. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology. 1987 Aug;61(4):457–461. [PMC free article] [PubMed] [Google Scholar]
  4. Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkawa U., Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem. 1982 Jul 10;257(13):7847–7851. [PubMed] [Google Scholar]
  5. Coussens L., Parker P. J., Rhee L., Yang-Feng T. L., Chen E., Waterfield M. D., Francke U., Ullrich A. Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science. 1986 Aug 22;233(4766):859–866. doi: 10.1126/science.3755548. [DOI] [PubMed] [Google Scholar]
  6. DeLisi C., Berzofsky J. A. T-cell antigenic sites tend to be amphipathic structures. Proc Natl Acad Sci U S A. 1985 Oct;82(20):7048–7052. doi: 10.1073/pnas.82.20.7048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Delclos K. B., Nagle D. S., Blumberg P. M. Specific binding of phorbol ester tumor promoters to mouse skin. Cell. 1980 Apr;19(4):1025–1032. doi: 10.1016/0092-8674(80)90093-8. [DOI] [PubMed] [Google Scholar]
  8. Deleers M., Brasseur R., Ruysschaert J. M., Malaisse W. J. Conformational analysis of phorbol esters at a simulated membrane/water interface. Biophys Chem. 1983 Jun;17(4):313–319. doi: 10.1016/0301-4622(83)80016-7. [DOI] [PubMed] [Google Scholar]
  9. Germain R. N. Immunology. The ins and outs of antigen processing and presentation. Nature. 1986 Aug 21;322(6081):687–689. doi: 10.1038/322687a0. [DOI] [PubMed] [Google Scholar]
  10. Hara T., Fu S. M. Human T cell activation. I. Monocyte-independent activation and proliferation induced by anti-T3 monoclonal antibodies in the presence of tumor promoter 12-o-tetradecanoyl phorbol-13 acetate. J Exp Med. 1985 Apr 1;161(4):641–656. doi: 10.1084/jem.161.4.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mastro A. M., Pepin K. G. A comparison of the mitogenic effects of a phorbol ester on lymphocytes from bovine spleen, lymph node and peripheral blood. Comp Immunol Microbiol Infect Dis. 1983;6(3):201–208. doi: 10.1016/0147-9571(83)90011-5. [DOI] [PubMed] [Google Scholar]
  12. Nishizuka Y. Perspectives on the role of protein kinase C in stimulus-response coupling. J Natl Cancer Inst. 1986 Mar;76(3):363–370. [PubMed] [Google Scholar]
  13. Nunn J. D., Katz D. R., Barker S., Fraher L. J., Hewison M., Hendy G. N., O'Riordan J. L. Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. Immunology. 1986 Dec;59(4):479–484. [PMC free article] [PubMed] [Google Scholar]
  14. O'Flynn K., Zanders E. D., Lamb J. R., Beverley P. C., Wallace D. L., Tatham P. E., Tax W. J., Linch D. C. Investigation of early T cell activation: analysis of the effect of specific antigen, interleukin 2 and monoclonal antibodies on intracellular free calcium concentration. Eur J Immunol. 1985 Jan;15(1):7–11. doi: 10.1002/eji.1830150103. [DOI] [PubMed] [Google Scholar]
  15. Palacios R. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody. Eur J Immunol. 1985 Jul;15(7):645–651. doi: 10.1002/eji.1830150702. [DOI] [PubMed] [Google Scholar]
  16. Robinson J. M., Badwey J. A., Karnovsky M. L., Karnovsky M. J. Release of superoxide and change in morphology by neutrophils in response to phorbol esters: antagonism by inhibitors of calcium-binding proteins. J Cell Biol. 1985 Sep;101(3):1052–1058. doi: 10.1083/jcb.101.3.1052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Shoyab M., Todaro G. J. Specific high affinity cell membrane receptors for biologically active phorbol and ingenol esters. Nature. 1980 Dec 4;288(5790):451–455. doi: 10.1038/288451a0. [DOI] [PubMed] [Google Scholar]
  18. Weiss A., Wiskocil R. L., Stobo J. D. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J Immunol. 1984 Jul;133(1):123–128. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES